Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGI

Impact of Y-90 glass microspheres residue measurement post-TARE using PET/CT on the tumor absorbed dose in comparison to planned dosimetry with Tc99m MAA scintigraphy.

Sarah Boughdad, Rafael DURAN, John Prior, Michael Mota, Melanie Mendes De Carvalho, Julien Costes, Silvano Gnesin and Niklaus Schaefer
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 3038;
Sarah Boughdad
1Lausanne University Hospital (Centre Hospitalier Universitaire Vaudois)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rafael DURAN
1Lausanne University Hospital (Centre Hospitalier Universitaire Vaudois)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Prior
2Lausanne University Hospital Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Mota
3CHUV
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melanie Mendes De Carvalho
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julien Costes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silvano Gnesin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Niklaus Schaefer
4Centre Hospitalier Universitaire Vaudois (CHUV)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 63 no. supplement 2 3038

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online August 8, 2022.

Copyright & Usage 
© 2022

Author Information

  1. Sarah Boughdad,
  2. Rafael DURAN1,
  3. John Prior2,
  4. Michael Mota3,
  5. Melanie Mendes De Carvalho,
  6. Julien Costes,
  7. Silvano Gnesin and
  8. Niklaus Schaefer4
  1. 1Lausanne University Hospital (Centre Hospitalier Universitaire Vaudois)
  2. 2Lausanne University Hospital Switzerland
  3. 3CHUV
  4. 4Centre Hospitalier Universitaire Vaudois (CHUV)

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: August 2022 to April 2025

AbstractFullPdf
Aug 20222100
Sep 20221500
Oct 2022700
Nov 20222600
Dec 20221900
Jan 20232100
Feb 20231100
Mar 20231100
Apr 2023500
May 2023700
Jun 20231400
Jul 2023800
Aug 2023500
Sep 2023800
Oct 20231500
Nov 2023200
Dec 20231200
Jan 20241400
Feb 2024600
Mar 20241300
Apr 20243600
May 20241200
Jun 20243000
Jul 202412000
Aug 20248800
Sep 20241400
Oct 20241100
Nov 2024500
Dec 20241400
Feb 20252500
Mar 20251000
Apr 20251000
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Impact of Y-90 glass microspheres residue measurement post-TARE using PET/CT on the tumor absorbed dose in comparison to planned dosimetry with Tc99m MAA scintigraphy.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Impact of Y-90 glass microspheres residue measurement post-TARE using PET/CT on the tumor absorbed dose in comparison to planned dosimetry with Tc99m MAA scintigraphy.
Sarah Boughdad, Rafael DURAN, John Prior, Michael Mota, Melanie Mendes De Carvalho, Julien Costes, Silvano Gnesin, Niklaus Schaefer
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 3038;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Impact of Y-90 glass microspheres residue measurement post-TARE using PET/CT on the tumor absorbed dose in comparison to planned dosimetry with Tc99m MAA scintigraphy.
Sarah Boughdad, Rafael DURAN, John Prior, Michael Mota, Melanie Mendes De Carvalho, Julien Costes, Silvano Gnesin, Niklaus Schaefer
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 3038;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Evaluation of advanced hepatocellular carcinoma with 68Ga-PSMA PET/CT, a prospective study!
  • 68Ga - Labeled Prostate Specific membrane Antigen PET/CT for diagnosing patients with Hepatocellular Carcinoma : A Pilot Study
Show more GI

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire